Molecular characterization of the 1p22 breakpoint region spanning the constitutional translocation breakpoint in a neuroblastoma patient with a t(1;10)(p22;q21)

Cancer Genetics and Cytogenetics

Volumn 100, Issue 1, 1998, Pages 10-20

  Roberts, Terry ^a   Chernova, Olga ^a   Cowell, John K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOGENESIS; CHROMOSOME 1P; CHROMOSOME BREAKAGE; CHROMOSOME MAP; CHROMOSOME TRANSLOCATION 1; CHROMOSOME TRANSLOCATION 10; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ANALYSIS; HUMAN; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; YEAST ARTIFICIAL CHROMOSOME;

EID: 0031963355     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(97)00013-7     Document Type: Article

References (38)

1. 1. Parkin DM, Stiller CA, Diever CA (1988): International incidence of childhood cancer. Int J Cancer 42:511-552.
2. 2. Roald B, Ninane J (1995): Neuroblastoma. In: The Oxford Textbook of Oncology, vol 2. M Peckham, H Pinedo, U Versonesi, eds. pp. 1992-2000.
3. 3. Knudson AG, Strong LC (1972): Mutation and cancer: neuroblastoma and pheochromocytoma. Am J Hum Genet 24:514-532.
4. 4. Riccardi VM, Sujansky E, Smith AC, Francke U (1978): Chromosome imbalance in the aniridia-Wilms' tumour association: 11p interstitial deletion. Pediatrics 61:604-610.
5. 5. Cowell JK, Hungerford J, Rutland P, Jay M (1989): Genetic and cytogenetic analysis of patients showing reduced esterase-D levels and mental retardation from a survey of 500 individuals with retinoblastoma. Ophthal Paed Genet 10:117-127.
6. 6. Ledbetter DH, Riccardi VM, Airhart SD, Strobel RJ, Keenan BS, Crawford JD (1981): Deletions of chromosome 15 as a cause of the Prader-Willi syndrome. New Engl J Med 304:325-329.
7. 7. Mead RS, Cowell JK (1995): Molecular characterization of a t(1;10)(p22;q21) constitutional translocation from a patient with neuroblastoma. Cancer Genet Cytogenet 81:151-157.
8. 8. Petkovic I, Nakic M, Cepulic M, Konja J (1993): Chromosomal analysis of two neuroblastomas. Cancer Genet Cytogenet 65:167-169.
9. 9. Christiansen H, Lampert F (1988): Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma. Br J Cancer 57:121-126.
10. 10. Combaret V, Turc-Carel C, Thiesse P, Rebillard A, Frappaz D, Haus O, Phillip T, Favrot MC (1995): Sensitive detection of numerical and structural aberrations of chromosome 1 in neuroblastoma by interphase fluorescence in situ hybridization. Comparison with restriction fragment length polymorphism and conventional cytogenetic analysis. Int J Cancer 61:185-191.
11. 11. Albertsen HM, Abderrahim H, Cann HM, Dausset J, Le Paslier D, Cohen D (1990): Construction and characterization of a yeast artificial chromosome library containing seven haploid human genome equivalents, Proc Natl Acad Sci USA 87:4256-4260.
12. 12. Larin Z, Monaco AP, Lehrach H (1991): Yeast artificial chromosome libraries containing large inserts from mouse and human DNA. Proc Natl Acad Sci USA 88:4123-4127.
13. 13. Anand R, Riley JH, Butler R, Smith JC, Markham AF (1990): A 3.5 genome equivalent multi access YAC library: Construction, characterisation, screening and storage. Nucleic Acids Res 18:124-130.
14. 14. Green ED, Olson MV (1990): Systematic screening of yeast artificial chromosome libraries using the polymerase chain reaction. Proc Natl Acad Sci USA 87:1213-1217.
15. 15. Riley J, Butler R, Ogilvie D, Finniear R, Jenner D, Powell S, Annand R, Smith JC, Markham AF (1990): A novel, rapid method for the isolation of terminal sequences from yeast artificial chromosome (YAC) clones. Nucleic Acids Res 18:2887.
16. 16. Sanger F, Nicklen S, Coulsen AR (1977): DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5462-5467.
17. 17. Lewis BC, Shah NP, Braun BS, Denny CT (1992): Creation of a yeast artificial chromosome fragmentation vector based on Lysine-2. GATA 9:86-90.
18. 18. Sambrook J, Fritsch EF, Maniatis T (1989): Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
19. 19. Feinberg AP, Vogelstein B (1983): A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13.
20. 20. Kempski H, MacDonald D, Michalski AJ, Roberts T, Goldman JM, Cross CP, Cowell JK (1995): Localisation of the 8;13 translocation breakpoint associated with myeloproliferative disease to a 1.5 Mbp region of chromosome 13. Genes Chromosom Cancer 12:283-287.
21. 21. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, Marc S, Bernardi G, Lathrop M, Weissenbach J (1994): The 1993-1994 Genethon human genetic linkage map. Nature Genet 7:246-339.
22. 22. Collins A, Keats BJ, Dracopoli N, Shields DC, Morton NE (1992): Integration of gene maps: Chromosome 1. Proc Natl Acad Sci USA 89:4598-4602,
23. 23. Roberts T, Mead RS, Cowell JK (1996): Characterisation of a human chromosome 1 somatic cell hybrid mapping panel and regional assignment of 6 novel STS. Ann Hum Genet 60:213-220.
24. 24. Roberts T, Auffray C, Cowell JK (1996): Regional localisation of 192 genie markers on human chromosome 1. Genomics 36:337-340.
25. 25. Frigerio JM, Dagorn JC, Iovanna JL (1995): Cloning, sequencing and expression of the L5, L21, L27a, L28, S5, S9, S10 and S29 human ribosomal protein mRNAs. Biochim Biophys Acta 1262:64-68.
26. 26. Hoggard N, Hey Y, Brintnell B, James L, Jones D, Mitchell E, Weissenbach J, Varley JM (1995): Identification and cloning in yeast artificial chromosomes of a region of elevated loss of heterozygosity on chromosome 1p31.1 in human breast cancer. Genomics 30:233-243.
27. 27. Bickmore WA, Bird AP (1992): Use of restriction endonuclease to detect and isolate genes from mammalian cells. Methods Enzymol 216:224-244.
28. 28. Kaplan J, Gerber S, Larget-Piet D, Rozet JM, Dollfus H, Dufier JL, Odent S, Postel-Vinay A, Janin N, Briard ML, Frezal J, Munnich A (1993): A gene for Stargardt's disease (fundus flavimaculatus) maps to the short arm of chromosome 1. Nature Genet 5:308-311.
29. 29. Gerber S, Rozet JM, Bonneau D, Souied E, Camuzat A, Dufier JL, Amalric P, Weissenbach J, Munnich A, Kaplan J (1995): A gene for late-onset fundus flavimaculatus with macular dystrophy maps to chromosome 1p13. Am J Hum Genet 56:396-399.
30. 30. Hoggard N, Brintnell B, Howell A, Weissenbach J, Varley J (1995): Allelic imbalance on chromosome 1 in human breast cancer, II. Microsatellite repeat analysis. Genes Chromosome Cancer 12:24-31.
31. 31. Bieche I, Champeme MH, Matifas F, Cropp C, Cannahan R, Lidereau R (1994): Demonstration of two regions involved in chromosome 1p deletion in breast tumors. Bulletin du Cancer 81:108-113.
32. 32. Mathew S, Murty VVS, Bosl GJ, Chaganti RSK (1994): Loss of male germ heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human cell tumors. Cancer Res 54:6265-6269.
33. 33. Kools PFJ, Wanschura S, Schoenmaker EPM, Geurts JMW, Mols R, Kazmierczak B, Bullerdiek J, Berghe HVD, Van de Ven WJM (1995): Identification of the chromosome 12 translocation breakpoint region of a pleomorphic salivary gland adenoma with t(1;12)(p22;q15) as the sole cytogenetic abnormality. Cancer Genet Cytogenet 79:1-7.
34. 34. Khosla S, Patel VM, Hay ID, Schaid DJ, Grant CS, van Heerden JA, Thibodeau SN (1991): Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas. J Clin Invest 87:1691-1699.
35. 35. Simon D, Knowles BB, Weith A (1991): Abnormalities of chromosome 1 and loss of heterozygosity on 1p in primary hepatomas. Oncogene 6:765-770.
36. 36. Biegel JA, White PS, Marshall HN, Fujimori M, Zackai EH, Scher CD, Brodeur GM, Emanuel BS (1993): Constitutional 1p36 deletion in a child with neuroblastoma. Am J Hum Genet 52:176-182.
37. 37. Laureys G, Speleman G, Opdenakker G, Benoit Y, Leroy J (1990): Constitutional translocation t(1;17)(p36;q12-21) in a patient with neuroblastoma. Genes Chromosom Cancer 2:252-254.
38. 38. Michalski AJ, Cotter FE, Cowell JK (1992): Isolation of chromosome specific DNA sequences from an Alu PCR library to define the breakpoint in a patient with a constitutional translocation t{(1;13)(q22;q12) and ganglioneuroblastoma. Oncogene 7:1595-1602.